The cGAS-STING pathway is critical for anti-tumour immunity via the recognition of damage-associated molecular patterns (DAMPs), primarily tumour-derived DNA [41], therefore inhibition of C5aR2 may amplify the host innate immune response to drive tumour clearance. The gene discussed is CGAS; the disease is neoplasm.